The Conversation (0)
Genedrive Announces CE-IVD Certification for Genotyping Test
Nov. 17, 2016 07:49AM PST
Medical Device InvestingGenedrive today announces its rapid Genedrive IL28B SNP human genotyping test has received CE-IVD certification.
Genedrive (LSE:GDR) today announces its rapid Genedrive IL28B SNP human genotyping test has received CE-IVD certification.
According to the press release:
The test is performed in 50 minutes from a buccal cheek swab using the Genedrive® hand-held real-time PCR instrument. The CE-IVD certification further validates Genedrive® as a technology platform for pharmacogenomics.
CEO David Budd said the following:
We are now looking to partner with Pharma and Contract Research Organisations to support the development of SNP assays for clinical trials and clinical applications. Through our development of the IL28B test, we have defined a rapid pathway for the generation of a quick, accurate, and effective human genotyping tests that can be deployed at the point of need.